Pfizer Inc. (PFE) Tops Earnings Estimates With 20% Jump In Q1 Revenue

UPDATE: 6:45 a.m. EDT — Pfizer on Tuesday reported earnings of 67 cents a share in the first quarter of 2016, topping analysts' estimates of 55 cents a share. Revenue for the three-month period ending March 31, boosted by its cancer drug sales and acquisition of Hospira in September, also beat estimates, coming in at $13.01 billion — a jump of 20 percent over the year-earlier figure of $18.86 billion and almost $1 billion more than the Reuters' forecast of $12.02 billion.

What feeling does this article give you?

#hashtags to follow:

March 31 [+]    Hospira [+]    Reuters [+]   

More #news: